Noninvasive Assessment of Liver Fibrosis: Current and Future Clinical and Molecular Perspectives
Liver fibrosis is one of the risk factors for hepatocellular carcinoma (HCC) development. The staging of liver fibrosis can be evaluated only via a liver biopsy, which is an invasive procedure. Noninvasive methods for the diagnosis of liver fibrosis can be divided into morphological tests such as el...
Main Authors: | Ryota Masuzaki, Tatsuo Kanda, Reina Sasaki, Naoki Matsumoto, Masahiro Ogawa, Shunichi Matsuoka, Seth J. Karp, Mitsuhiko Moriyama |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/14/4906 |
Similar Items
-
Suppressors of Cytokine Signaling and Hepatocellular Carcinoma
by: Ryota Masuzaki, et al.
Published: (2022-05-01) -
Cell Culture Systems and Drug Targets for Hepatitis A Virus Infection
by: Tatsuo Kanda, et al.
Published: (2020-05-01) -
Noninvasive Liver Fibrosis Staging: Comparison of MR Elastography with Extracellular Volume Fraction Analysis Using Contrast-Enhanced CT
by: Keigo Yano, et al.
Published: (2022-09-01) -
Different Mechanisms of Action of Regorafenib and Lenvatinib on Toll-Like Receptor-Signaling Pathways in Human Hepatoma Cell Lines
by: Reina Sasaki, et al.
Published: (2020-05-01) -
Noninvasive assessment of liver fibrosis: Serum markers and transient elastography (FibroScan) Evaluación no invasiva de fibrosis hepática: Marcadores séricos y elastografía transitoria (FibroScan)
by: J. C. Marín-Gabriel, et al.
Published: (2009-11-01)